Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Nilotinib in Growing Vestibular Schwannomas

This study has been terminated.
(Study PI passed away We had trouble recruiting for the drug arm)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01201538
First received: September 13, 2010
Last updated: March 11, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2013
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)